Designing drug trials for Alzheimer’s disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force
Titel:
Designing drug trials for Alzheimer’s disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force
Auteur:
Vellas, Bruno Carrillo, Maria C. Sampaio, Cristina Brashear, H. Robert Siemers, Eric Hampel, Harald Schneider, Lon S. Weiner, Michael Doody, Rachelle Khachaturian, Zaven Cedarbaum, Jesse Grundman, Michael Broich, Karl Giacobini, Ezio Dubois, Bruno Sperling, Reisa Wilcock, Gordon K. Fox, Nick Scheltens, Philip Touchon, Jacques Hendrix, Suzanne Andrieu, Sandrine Aisen, Paul